Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous sildenafil versus nitric oxide for pulmonary vasoreactivity testing in pediatric pulmonary hypertension
2012-004583-22Phase 3Active
- Sponsor
- Ospedale Pediatrico Bambino Gesù
- Start
- Oct 2012
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sildenafil, nitric oxide in pulmonary hypertension (PH), sponsored by Ospedale Pediatrico Bambino Gesù. Started Oct 2012; status: active.
02
Drugs
sildenafilnitric oxide
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on 2012-004583-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004583-22.